Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Nanotechnology diagnostics for infectious diseases prevalent in developing countries.

Hauck TS, Giri S, Gao Y, Chan WC.

Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):438-48. doi: 10.1016/j.addr.2009.11.015. Epub 2009 Nov 24. Review.

PMID:
19931580
2.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
3.

Nano/Microfluidics for diagnosis of infectious diseases in developing countries.

Lee WG, Kim YG, Chung BG, Demirci U, Khademhosseini A.

Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):449-57. doi: 10.1016/j.addr.2009.11.016. Epub 2009 Nov 30. Review.

4.

Nanobioimaging and sensing of infectious diseases.

Tallury P, Malhotra A, Byrne LM, Santra S.

Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):424-37. doi: 10.1016/j.addr.2009.11.014. Epub 2009 Nov 25. Review.

PMID:
19931579
5.

[A decade of child health research in developing countries].

Orne-Gliemann J, Perez F, Leroy V, Newell ML, Dabis F.

Sante. 2003 Apr-Jun;13(2):69-75. Review. French.

PMID:
14530116
6.

Laboratory challenges in the scaling up of HIV, TB, and malaria programs: The interaction of health and laboratory systems, clinical research, and service delivery.

Birx D, de Souza M, Nkengasong JN.

Am J Clin Pathol. 2009 Jun;131(6):849-51. doi: 10.1309/AJCPGH89QDSWFONS. Review.

7.

Point-of-care tests for diagnosing infections in the developing world.

Peeling RW, Mabey D.

Clin Microbiol Infect. 2010 Aug;16(8):1062-9. doi: 10.1111/j.1469-0691.2010.03279.x. Review.

8.

The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives.

Vitoria M, Granich R, Gilks CF, Gunneberg C, Hosseini M, Were W, Raviglione M, De Cock KM.

Am J Clin Pathol. 2009 Jun;131(6):844-8. doi: 10.1309/AJCP5XHDB1PNAEYT. Review.

9.

[Current status of the female condom in Africa].

Deniaud F.

Sante. 1997 Nov-Dec;7(6):405-15. Review. French.

PMID:
9503499
10.

New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance.

Pai M, Kalantri S, Dheda K.

Expert Rev Mol Diagn. 2006 May;6(3):423-32. Review.

PMID:
16706744
11.

[Evolution of IGRA researches].

Ariga H, Harada N.

Kekkaku. 2008 Sep;83(9):641-52. Review. Japanese.

PMID:
18979999
12.

The application of microfluidic devices for viral diagnosis in developing countries.

Hattersley SM, Greenman J, Haswell SJ.

Methods Mol Biol. 2013;949:285-303. doi: 10.1007/978-1-62703-134-9_19. Review.

PMID:
23329450
13.
14.

The resurgence of tuberculosis.

Parry C, Davies PD.

Soc Appl Bacteriol Symp Ser. 1996;25:23S-26S. Review.

PMID:
8972116
15.

Nanotechnology applied to the treatment of malaria.

Santos-Magalhães NS, Mosqueira VC.

Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):560-75. doi: 10.1016/j.addr.2009.11.024. Epub 2009 Nov 13. Review.

PMID:
19914313
16.

The growing challenge of HIV/AIDS in developing countries.

Grant AD, De Cock KM.

Br Med Bull. 1998;54(2):369-81. Review.

17.

Nanotechnology and the diagnosis of dermatological infectious disease.

Blecher Paz K, Friedman A.

J Drugs Dermatol. 2012 Jul;11(7):846-51. Review.

PMID:
22777227
18.

Tuberculosis and HIV disease: two decades of a dual epidemic.

Aliyu MH, Salihu HM.

Wien Klin Wochenschr. 2003 Oct 31;115(19-20):685-97. Review.

PMID:
14650943
19.

The double burden of communicable and non-communicable diseases in developing countries.

Boutayeb A.

Trans R Soc Trop Med Hyg. 2006 Mar;100(3):191-9. Epub 2005 Nov 4. Review.

PMID:
16274715
20.

Nanotechnology-based systems for the treatment and prevention of HIV/AIDS.

das Neves J, Amiji MM, Bahia MF, Sarmento B.

Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):458-77. doi: 10.1016/j.addr.2009.11.017. Epub 2009 Nov 12. Review.

PMID:
19914314
Items per page

Supplemental Content

Write to the Help Desk